Search results for "VTE"
COVID-19 flu guidance, data on convalescent plasma, cardiac effects, and clot risk
Flu testing and treatment advice came from the NIH, convalescent plasma failed in a trial, new studies suggested looking out for myocardial injury and not overdoing thromboprophylaxis, and remdesivir got full approval, among other COVID-19 news.
https://acphospitalist.acponline.org/weekly/archives/2020/10/28/1.htm
28 Oct 2020
Guidelines offer 28 recommendations for initial management, secondary prevention of DVT and PE
Among other recommendations, the new guidelines from the American Society of Hematology suggest offering home treatment to low-risk patients with deep venous thrombosis (DVT) or pulmonary embolism (PE).
https://acphospitalist.acponline.org/weekly/archives/2020/10/21/3.htm
21 Oct 2020
Syncope, sepsis resuscitation, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/10/recent-research.htm
15 Oct 2020
PE risk assessment tools modestly effective for estimating mortality, study finds
The Pulmonary Embolism Severity Index (PESI), the simplified PESI (sPESI), the Bova score, and a risk assessment method from the European Society of Cardiology were evaluated.
https://acphospitalist.acponline.org/weekly/archives/2020/09/02/3.htm
2 Sep 2020
Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and the authorization for use of remdesivir was expanded.
https://acphospitalist.acponline.org/weekly/archives/2020/09/02/1.htm
2 Sep 2020
COVID-19 research focuses on steroids, clots, hydroxychloroquine, zinc
Steroids' effects varied by C-reactive protein level, clots occurred despite prophylaxis, and hydroxychloroquine and zinc were ineffective for COVID-19, according to newly published studies.
https://acphospitalist.acponline.org/weekly/archives/2020/07/29/1.htm
29 Jul 2020
Bedside sitters, pneumothorax, and more
Research summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/07/in-the-news.htm
15 Jul 2020
Cases from Oregon Health & Science University
Thrombus-in-transit, serotonin syndrome, leptospirosis, and more.
https://acphospitalist.acponline.org/archives/2020/07/brief-case-from-oregon-health-and-science-university.htm
15 Jul 2020
Rivaroxaban after discharge may reduce thromboembolic risk in medically ill
An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/3.htm
24 Jun 2020
DVT and PE
Documentation of deep venous thrombosis (DVT) and pulmonary embolism (PE) requires knowledge of certain criteria.
https://acphospitalist.acponline.org/archives/2020/06/coding-corner-dvt-and-pe.htm
15 Jun 2020